Streamline Ag, LLC – Trademark Portfolio
Entity Type: 16
Streamline Ag, LLC holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 34 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 21 trademarks are registered and 6 are pending. Notable registered marks include BIOUP, NCASE, NGEST, NBRACE, and UPZYME. The owner is based in Elkhorn, NE.
1015 North 205th Street
Elkhorn, NE 68022
Showing of trademarks Trademarks
Trademark Classifications
Streamline Ag, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Streamline Ag, LLC have?
Streamline Ag, LLC has 36 U.S. trademarks filed with the USPTO. Of these, 21 registered, 6 pending, 9 abandoned.
What trademark classes does Streamline Ag, LLC file in?
Streamline Ag, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Streamline Ag, LLC's most well-known trademarks?
Streamline Ag, LLC's registered trademark portfolio includes well-known marks such as BIOUP, NCASE, NGEST, NBRACE, and UPZYME. These are among 21 currently registered trademarks in the portfolio.
What is Streamline Ag, LLC's trademark registration success rate?
Streamline Ag, LLC has a 70% trademark registration rate, with 21 out of 30 resolved applications resulting in successful registration. Currently, 6 applications are pending review.